IP Verse

Frese competitive analysis

Latest oppositions filed by Frese

Explore patent oppositions filed by Frese against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jan 29, 2026
Patent NumberTitleApplicantOpposition Date
EP3329965
Dosing Regimen Of Anti-Alpha4Beta7-AntibodiesMILLENNIUM PHARMACEUTICALSDec 18, 2025
EP3773013
Insulin Control In Overweight Or Obese Adult During Life Time InterventionNUTRICIADec 12, 2025
EP3842084
Apparatus For Extracorporeal Blood TreatmentGAMBRO LUNDIANov 12, 2025
EP4203982
Combination Of Collagen Peptide And Whey Protein For Use In A Condition Of The Skeletal TissueROUSSELOTNov 7, 2025
EP4392050
Collagen Hydrolysate For Use In Prevention And/Or Treatment Of Post Intensive Care Syndrome (Pics)ROUSSELOTNov 7, 2025
EP3890513
Food Or Beverage Product With Agglomerated Pea ProteinNESTLEOct 20, 2025
EP3982992
Use Of Whey Protein Micelles For Controlling Postprandial Glucose ResponseNESTLEOct 13, 2025
EP3236766
Product Comprising A Container And Whey ProteinCOMPAGNIE GERVAIS DANONESep 15, 2025
EP4051223
Composition Comprising Epa, Ma And Leucine For Improving Muscle FunctionNUTRICIAAug 13, 2025
EP3554250
A Method Of Producing A Dairy Concentrate With Free Divalent Cations Protein AggregationNESTLEJul 28, 2025

Latest patents of Frese opposed by its competitors

Explore Frese's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jan 29, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP4076384
Oct 22, 2025Method For Producing Oil-In-Water Emulsions1
EP2854768
Jun 18, 2025Pharmaceutical Compositions Of Pemetrexed3
EP3383202
Apr 2, 2025High Protein Enteral Tube Feed For Icu Patients1
EP3914315
Dec 25, 2024Device For An Extracorporeal Blood Treatment1
EP3411016
Sep 11, 2024High Caloric, High Protein Nutritional Formula1
EP3525781
Apr 24, 2024Composition Comprising Epa And Dha For An Enhanced Efficacy Of Anticancer Agents1
EP3218044
Apr 3, 2024Needleless, Intermittent, Neutral Displacement Iv Injection Port1
EP3131518
Feb 7, 2024Multichamber Bag Opening Aid1
EP3641873
Jan 10, 2024Needleless Iv Injection Port1
EP3411057
Dec 20, 2023High Caloric, High Protein Nutritional Formula Comprising Collagen1

Latest PTAB cases involving Frese

Discover the latest PTAB cases involving Frese, highlighting their recent legal challenges and patent disputes.

Last updated on: Feb 3, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Frese

IPR2025-01268Jul 14, 2025FRESENIUS KABI SWISSBIOSIMREGENERON PHARMACEUTICALSPending Director Review
IPR2025-01269Jul 14, 2025FRESENIUS KABI SWISSBIOSIMREGENERON PHARMACEUTICALSInstitution Denied
IPR2022-01065Jun 7, 2022FRESENIUS KABI USACHUGAI SEIYAKU KABUSHIKI KAISHATerminated-Settled
IPR2022-00657Mar 3, 2022FRESENIUS KABI USANOVO NORDISKTerminated-Settled
IPR2022-00201Nov 24, 2021FRESENIUS KABI USACHUGAI SEIYAKU KABUSHIKI KAISHA CHUGAI PHARMACEUTICALTerminated-Settled
IPR2021-01542Sep 24, 2021FRESENIUS KABI USACHUGAI SEIYAKU KABUSHIKI KAISHA CHUGAI PHARMACEUTICALTerminated-Settled
IPR2021-01288Aug 18, 2021FRESENIUS KABI USACHUGAI SEIYAKU KABUSHIKI KAISHA CHUGAI PHARMACEUTICALTerminated-Settled
IPR2021-01336Aug 18, 2021FRESENIUS KABI USACHUGAI SEIYAKU KABUSHIKI KAISHA CHUGAI PHARMACEUTICALTerminated-Settled
IPR2021-01024Jun 28, 2021FRESENIUS KABI USACHUGAI SEIYAKU KABUSHIKI KAISHA CHUGAI PHARMACEUTICALTerminated-Settled
IPR2021-01025Jun 28, 2021FRESENIUS KABI USACHUGAI SEIYAKU KABUSHIKI KAISHA CHUGAI PHARMACEUTICALTerminated-Settled

Peer Comparison New

IP litigation analysis comparing Frese with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 29, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
FRESENIUS KABI DEUTSCHLAND12419 - -
NESTEC3187 - -
NESTLE179229 - -
NUTRICIA163128 - -